Guardian Pharmacy shares rise 3% in lukewarm NYSE debut
Sept 26 (Reuters) - Guardian Pharmacy's GRDN.N shares rise 3.3% in their NYSE debut, giving the healthcare firm a market valuation of about $880 million. (Reporting by Jaiveer Singh Shekhawat in Bengaluru; Editing by Shreya Biswas ) ((JaiveerSingh.Shekhawat@thomsonreuters.com;))
Recent news on Guardian Pharmacy Services
See all newsU.S. RESEARCH ROUNDUP- Datadog, Jabil, Prologis
Brief: Guardian Pharmacy Services - Enters Eighth Amendment To Loan And Security Agreement On May 21, 2026
Guardian Pharmacy tops Q1 revenue estimates, maintains 2026 revenue forecast
U.S. RESEARCH ROUNDUP- Ferguson Enterprises, Hartford Insurance Group, JP Morgan
U.S. STOCKS ON THE MOVE-Darden Restaurants, Mastercard, Accenture